Company Overview - Biohaven Ltd. (BHVN) is a clinical-stage biopharmaceutical company with a diverse pipeline focused on neuroscience, immunology, muscle and metabolism, and oncology [1]. Recent Developments - The Phase 2 depression trial for Opakalim (BHV-7000) did not meet its primary endpoint, leading the company to discontinue its psychiatric research [1].